Cardiac Wire #64 March 13, 2023
Young Adult Risks Predict CVD Tsunami | Pacemaker Harvest
Cardiac Wire #63 March 9, 2023
Top 8 of ACC 2023 | Esperion’s CLEAR Outcomes
Cardiac Wire #62 March 6, 2023
Low LDL-C Benefits | More RDN Evidence
Cardiac Wire #61 March 2, 2023
Novice Heart Failure Screening | Renal Denervation’s Comeback
Cardiac Wire #60 February 27, 2023
LDL-TG’s Atherosclerosis Impact | Sad LAAO Science
Cardiac Wire #59 February 21, 2023
Lasting CV Risks After Complicated Pregnancies | JACC Editor Interviews ChatGPT
Cardiac Wire #58 February 16, 2023
GE Acquires Caption Health | Aspirin Risks Exceed Benefits
Cardiac Wire #57 February 13, 2023
Biosense Webster’s PFA Milestone | Forxiga’s Expanded Approval
Cardiac Wire #56 February 9, 2023
Challenging the HFpEF Treatment Dogma | Heart Disease Risk Perceptions
Cardiac Wire #55 February 6, 2023
The Power of Low Lifelong LDL-C | Abbott’s Catheter Ablation Approvals
Cardiac Wire #54 February 2, 2023
Echo AI Model for CAC Scoring | Eli Lilly Bolsters Manufacturing for GLP-1 Agonists
Cardiac Wire 53 January 30, 2023
AVS Series B | Wearable Cardiac Ultrasound
January 26, 2023
Improving Chest Pain Triage | Empagliflozin’s CKD Impact
Cardiac Wire #51 January 23, 2023
Intermittent Fasting Long Term? | Abbott’s Next-Gen Device Approval
Cardiac Wire #50 January 19, 2023
CAPLA: Simple Ablation is Best | Shockwave Acquires Neovasc
Cardiac Wire #49 January 16, 2023
Wegovy Approved for Teens | Public Interest in CPR Spikes
Cardiac Wire #48 January 12, 2023
Unraveling the Myocarditis Mystery | AstraZeneca Acquires CinCor
Cardiac Wire #47 January 9, 2023
Repatha Analysis Raises Questions | Unlocking the Potential of Genetic Testing
Cardiac Wire #46 January 4, 2023
